Natriuretic Peptides as Markers of Left Ventricular Reverse Remodeling After Angiotensin Receptor-Neprilysin Inhibitor Therapy

Q: What is the clinical evidence from this study?

Study design: Editorial. Population: Heart failure (n=49). Intervention: Angiotensin receptor-neprilysin inhibitor (ARNI).

Koki Nakanishi; Hiroyuki Morita

doi:10.1536/ihj.23-525

November 29, 2023International Heart JournalOpen Access

Natriuretic Peptides as Markers of Left Ventricular Reverse Remodeling After Angiotensin Receptor-Neprilysin Inhibitor Therapy

View Full Paper

Ask AI

Bookmark

Share

Key result

Decreases in NT-proBNP and increases in ANP levels after ARNI therapy were associated with favorable left ventricular reverse remodeling in patients with heart failure.

Structured PICO

P

Population

Editorial discussing a study of 49 patients with heart failure evaluating temporal trends in natriuretic peptide levels before and after ARNI therapy.

I

Intervention

Angiotensin receptor-neprilysin inhibitor (ARNI) therapy

Limitations

Natriuretic peptide levels are affected by clinical factors such as age, obesity, renal function, and atrial fibrillation.
Less than 10% of patients in the discussed study had ischemic etiology, limiting applicability to different clinical situations.
Mechanisms underlying the relationships among ARNI therapy, changes in natriuretic peptides, and cardiac reverse remodeling remain unknown.
The impact of natriuretic peptide levels on long-term cardiac remodeling warrants further exploration.
Natriuretic peptide levels are affected by clinical factors like age, obesity, renal function, and AF
Small proportion of ischemic etiology in the discussed study limits applicability
Mechanisms underlying relationships among ARNI, natriuretic peptides, and reverse remodeling remain unknown
Impact on long-term cardiac remodeling needs exploration

Implication

Changes in natriuretic peptide levels, specifically increased ANP and decreased NT-proBNP, may serve as useful markers for predicting left ventricular reverse remodeling in heart failure patients treated with ARNI.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Nakanishi et al. (2023) conducted an editorial in Heart failure (n=49). Angiotensin receptor-neprilysin inhibitor (ARNI) was evaluated. Decreases in NT-proBNP and increases in ANP levels after ARNI therapy were associated with favorable left ventricular reverse remodeling in patients with heart failure.

synapsesocial.com/papers/6a2100a2894b966f6186df6c https://doi.org/10.1536/ihj.23-525

Topics

HFrEF treatment

Heart failure

View Full Paper

Ask AI

Bookmark

Share

Natriuretic Peptides as Markers of Left Ventricular Reverse Remodeling After Angiotensin Receptor-Neprilysin Inhibitor Therapy

Structured PICO

Limitations

Implication

Discussion

Cite This Study

Topics

Natriuretic Peptides as Markers of Left Ventricular Reverse Remodeling After Angiotensin Receptor-Neprilysin Inhibitor Therapy

Structured PICO

Limitations

Implication

Discussion

Cite This Study

Keep reading

Topics

Keep reading